Palantir surged as much as 17% on Monday following a Bloomberg report that said the data-mining firm won a three-year contract with the US Food and Drug Administration. The contract is worth $44.4 million, Bloomberg said, adding that it will allow the FDA to utilize Palantir's software to integrate and analyze data.
Palantir surges 17% after it wins FDA contract worth $44 million, report says (PLTR)